TABLE 2.
Tumor and Treatment Characteristics for Women Living in Advantaged Versus Disadvantaged Neighborhoods in New York City
| Characteristic | Total | Advantaged neighborhood (ADI 1–3), N (%) | Disadvantaged neighborhood (ADI 4–10), N (%) | P |
|---|---|---|---|---|
| N | 5452 | 3479 (63.8) | 1973 (36.2) | |
| Clinical stage | ||||
| 1 | 3164 | 2801 (62.6) | 1083 (58.0) | 0.002 |
| 2 | 1709 | 1036 (31.2) | 673 (36.0) | |
| 3 | 319 | 206 (6.2) | 113 (6.1) | |
| Tumor differentiation | ||||
| Well or moderately | 2297 | 1568 (64.6) | 729 (56.7) | <0.001 |
| Poorly | 1415 | 858 (35.4) | 557 (43.3) | |
| Tumor Subtype | ||||
| ER+/HER2− | 3411 | 2189 (73.3) | 1213 (69.5) | <0.001 |
| ER+/HER2+ | 402 | 263 (8.8) | 139 (8.0) | |
| ER−/HER2+ | 241 | 150 (5.0) | 91 (5.2) | |
| ER−/HER2− | 689 | 386 (12.9) | 303 (17.4) | |
| Chemotherapy | ||||
| No | 2906 | 1885 (54.2) | 1021 (51.8) | 0.083 |
| Yes | 2546 | 1594 (45.8) | 952 (48.3) | |
| Radiation | ||||
| No | 1815 | 1182 (34.0) | 633 (32.1) | 0.15 |
| Yes | 3637 | 2297 (66.0) | 1340 (67.9) | |
| Endocrine therapy | ||||
| No | 1095 | 630 (18.1) | 465 (23.6) | <0.001 |
| Yes | 4357 | 2849 (81.9) | 1508 (76.4) | |